Diversicare Of Hutchinson in Hutchinson, KS

Diversicare Of Hutchinson is a medicare and medicaid certified nursing home in Hutchinson, Kansas. It is located in Reno county at 1202 E 23rd Avenue, Hutchinson, Kansas 67502. You can reach out to the office of Diversicare Of Hutchinson via phone at (620) 669-9393. This skilled nursing facility has 73 federally certified beds with average occupancy rate of 68.9%. Its legal business name is Diversicare Of Hutchinson Llc and has the following ownership type - For Profit - Corporation.

Diversicare Of Hutchinson (Medicare CCN 175114) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1977 (47 years certified) and the last quality survey was conducted in November, 2019.

Name	Diversicare Of Hutchinson
Location	1202 E 23rd Avenue, Hutchinson, Kansas
Certified By	Medicare and Medicaid
No. of Certified Beds	73
Occupancy Rate	68.9%
Medicare ID (CCN)	175114
Legal Business Name	Diversicare Of Hutchinson Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Diversicare Of Hutchinson from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1164828174
Organization Name	DIVERSICARE OF HUTCHINSON, LLC
Doing Business As	DIVERSICARE OF HUTCHINSON
Address	1202 E 23rd Ave, Hutchinson, KS 67502
Phone Number	620-669-9393

News Archive

Phase 1 study results of TRU-016 in patients with CLL announced

BioteTrubion Pharmaceuticals, Inc. and Facet ch Corp. today announced the presentation of positive data from a phase 1 study of TRU-016 in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) at the 2009 American Society of Hematology (ASH) Annual Meeting.

ULURU reports Altrazeal clinical trial results

ULURU Inc. (NYSE Alternext: ULU) announced today the presentation of results from the first completed randomized clinical trial for Altrazeal at the SAWC Fall symposium in Washington D.C. September 16-18. The recently completed clinical study compared healing, pain and comfort of skin graft donor sites treated with either Altrazeal(TM) or with a leading commercial sodium carboxymethylcellulose-silver ("CMC-Ag") dressing.

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

Read more Medical News

› Verified 3 days ago

NPI Number	1871680058
Organization Name	THI OF KANSAS AT GOLDEN PLAINS, LLC
Doing Business As	GOLDEN PLAINS HEALTHCARE CENTER
Address	1202 E 23rd Ave, Hutchinson, KS 67502
Phone Number	620-669-9393

News Archive

Phase 1 study results of TRU-016 in patients with CLL announced

BioteTrubion Pharmaceuticals, Inc. and Facet ch Corp. today announced the presentation of positive data from a phase 1 study of TRU-016 in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) at the 2009 American Society of Hematology (ASH) Annual Meeting.

ULURU reports Altrazeal clinical trial results

ULURU Inc. (NYSE Alternext: ULU) announced today the presentation of results from the first completed randomized clinical trial for Altrazeal at the SAWC Fall symposium in Washington D.C. September 16-18. The recently completed clinical study compared healing, pain and comfort of skin graft donor sites treated with either Altrazeal(TM) or with a leading commercial sodium carboxymethylcellulose-silver ("CMC-Ag") dressing.

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

Read more Medical News

› Verified 3 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Diversicare Of Hutchinson are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Diversicare Of Hutchinson give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Phase 1 study results of TRU-016 in patients with CLL announced

BioteTrubion Pharmaceuticals, Inc. and Facet ch Corp. today announced the presentation of positive data from a phase 1 study of TRU-016 in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) at the 2009 American Society of Hematology (ASH) Annual Meeting.

ULURU reports Altrazeal clinical trial results

ULURU Inc. (NYSE Alternext: ULU) announced today the presentation of results from the first completed randomized clinical trial for Altrazeal at the SAWC Fall symposium in Washington D.C. September 16-18. The recently completed clinical study compared healing, pain and comfort of skin graft donor sites treated with either Altrazeal(TM) or with a leading commercial sodium carboxymethylcellulose-silver ("CMC-Ag") dressing.

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

Read more Medical News

› Verified 3 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Diversicare Of Hutchinson is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	12.65	14.46
Percentage of long-stay residents who lose too much weight	1.41	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	50	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0	1.79
Percentage of long-stay residents with a urinary tract infection	0	2.65
Percentage of long-stay residents who have depressive symptoms	1.59	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	1.53	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	100	93.87
Percentage of long-stay residents who received an antipsychotic medication	5.49	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	94.58	83.88
Percentage of short-stay residents who newly received an antipsychotic medication	0	1.79
Percentage of long-stay residents whose ability to move independently worsened	13.87	17.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication	19.88	19.7
Percentage of high risk long-stay residents with pressure ulcers	2.33	7.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine	99.07	95.98
Percentage of short-stay residents who made improvements in function	96.51	67.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine	93.22	82.93

Nursing Homes in Hutchinson, KS

Diversicare Of Hutchinson Location: 1202 E 23rd Avenue, Hutchinson, Kansas 67502 Phone: (620) 669-9393
Hutchinson Operator, Llc Location: 2301 N Severance Street, Hutchinson, Kansas 67502 Phone: (620) 662-0597
Good Samaritan Society - Hutchinson Village Location: 810 E 30th Avenue, Hutchinson, Kansas 67502 Phone: (620) 663-1189
Wesley Towers Inc Location: 700 Monterey Pl, Hutchinson, Kansas 67502 Phone: (620) 663-9175

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.